SEARCH

SEARCH BY CITATION

References

  • 1
    Münzer, T., Harman, S. M., Hees, P., et al. (2001) Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab. 86: 36043610.
  • 2
    Scacchi, M., Pincelli, A. I., Cavagnini, F. (1999) Growth hormone in obesity. Int J Obes Relat Metab Disord. 23: 260271.
  • 3
    Norrelund, H., Borglum, J., Jorgensen, J. O., et al. (2000) Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women. Clin Endocrinol (Oxf). 52: 305312.
  • 4
    Kim, K. R., Nam, S. Y., Song, Y. D., Lim, S. K., Lee, H. C., Huh, K. B. (1999) Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Horm Res. 51: 7884.
  • 5
    Johannsson, G., Mårin, P., Lönn, L., et al. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 82: 727734.
  • 6
    Mauras, N., O'Brien, K. O., Welch, S., et al. (2000) Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab. 85: 16861694.
  • 7
    Richelsen, B., Pedersen, S. B., Kristensen, K., et al. (2000) Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism. 49: 906911.
  • 8
    Bengtsson, B-A, Brummer, R-JM, Edén, S., Sjöström, L. (1992) Effects of growth hormone on fat mass and fat distribution. Acta Paediatr. 383: 6265.
  • 9
    Slavin, B. G., Ong, J. M., Kern, P. A. (1994) Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res. 35: 15351541.
  • 10
    DiGirolamo, M., Eden, S., Enberg, G., et al. (1986) Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes. FEBS Lett. 205: 1519.
  • 11
    Maccario, M., Grottoli, S., Procopio, M., et al. (2000) The GH/IGF-I axis in obesity: Influence of neuro-endocrine and metabolic factors. Int J Obes Relat Metab Disord. 24: S96S99.
  • 12
    Iranmanesh, A., Lizarralde, G., Veldhuis, J. D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73: 10811088.
  • 13
    Veldhuis, J. D., Iranmanesh, A., Ho, K. K., Waters, M. J., Johnson, M. L., Lizarralde, G. (1991) Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 72: 5159.
  • 14
    Richelsen, B., Pedersen, S. B., Børglum, J. D., Møller-Pedersen, T., Jørgensen, J., Jørgensen, J. O. (1994) Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am J Physiol. 266: E211E216.
  • 15
    Tagliaferri, M., Scacchi, M., Pincelli, A. I., et al. (1998) Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. Int J Obes Relat Metab Disord. 22: 836841.
  • 16
    Snyder, D. K., Clemmons, D. R., Underwood, L. E. (1988) Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects on anabolism, lipolysis, and body composition. J Clin Endocrinol Metab. 67: 5461.
  • 17
    Snyder, D. K., Underwood, L. E., Clemmons, D. R. (1995) Persistent lipolytic effect of exogenous growth hormone during caloric restriction. Am J Med. 98: 129134.
  • 18
    Drent, M. L., Wever, L. D. V., Adèr, H. J., van der Veen, E. A. (1995) Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects. Eur J Endocrinol. 132: 565572.
  • 19
    Snyder, D. K., Underwood, L. E., Clemmons, D. R. (1990) Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. Am J Clin Nutr. 52: 431437.
  • 20
    Skaggs, S. R., Crist, D. M. (1991) Exogenous human growth hormone reduces body fat in obese women. Horm Res. 35: 1924.
  • 21
    Thompson, J. L., Butterfield, G. E., Gylfadottir, U. K., et al. (1998) Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab. 83: 14771484.
  • 22
    Biller, B. M., Sesmilo, G., Baum, H. B., Hayden, D., Schoenfeld, D., Klibanski, A. (2000) Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab. 85: 970976.
  • 23
    Brummer, R-JM. (1998) Effects of growth hormone treatment on visceral adipose tissue. Growth Horm IGF Res. 8: 1923.
  • 24
    Russell-Jones, D. L., Bowes, S. B., Rees, S. E., et al. (1998) Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults. Am J Physiol. 274: E1050E1056.
  • 25
    Clemmons, D. R., Snyder, D. K., Williams, R., Underwood, L. E. (1987) Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab. 64: 878883.
  • 26
    Snyder, D. K., Clemmons, D. R., Underwood, L. E. (1989) Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans. J Clin Endocrinol Metab. 69: 745752.
  • 27
    Nam, S. Y., Kim, K. R., Cha, B. S., et al. (2001) Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 25: 11011107.
  • 28
    Gerard, J. M., Garibaldi, L., Myers, S. E., et al. (1997) Sleep apnea in patients receiving growth hormone. Clin Pediatr. 36: 321326.